nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—Gastrointestinal pain—Thiotepa—sarcoma	0.0019	0.0019	CcSEcCtD
Arformoterol—Ill-defined disorder—Etoposide—sarcoma	0.0019	0.0019	CcSEcCtD
Arformoterol—Gastrointestinal pain—Dactinomycin—sarcoma	0.00189	0.00189	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Vincristine—sarcoma	0.00188	0.00188	CcSEcCtD
Arformoterol—Hypotension—Mitoxantrone—sarcoma	0.00188	0.00188	CcSEcCtD
Arformoterol—Insomnia—Vincristine—sarcoma	0.00187	0.00187	CcSEcCtD
Arformoterol—Urticaria—Thiotepa—sarcoma	0.00185	0.00185	CcSEcCtD
Arformoterol—Malaise—Etoposide—sarcoma	0.00185	0.00185	CcSEcCtD
Arformoterol—Abdominal pain—Thiotepa—sarcoma	0.00184	0.00184	CcSEcCtD
Arformoterol—Body temperature increased—Thiotepa—sarcoma	0.00184	0.00184	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00183	0.00183	CcSEcCtD
Arformoterol—Body temperature increased—Dactinomycin—sarcoma	0.00183	0.00183	CcSEcCtD
Arformoterol—Abdominal pain—Dactinomycin—sarcoma	0.00183	0.00183	CcSEcCtD
Arformoterol—Hypoglycaemia—Doxorubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Arformoterol—Dyspnoea—Mitoxantrone—sarcoma	0.00179	0.00179	CcSEcCtD
Arformoterol—Cough—Etoposide—sarcoma	0.00179	0.00179	CcSEcCtD
Arformoterol—Somnolence—Mitoxantrone—sarcoma	0.00179	0.00179	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Vincristine—sarcoma	0.00178	0.00178	CcSEcCtD
Arformoterol—Fatigue—Vincristine—sarcoma	0.00178	0.00178	CcSEcCtD
Arformoterol—Dehydration—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Arformoterol—Dyspepsia—Mitoxantrone—sarcoma	0.00177	0.00177	CcSEcCtD
Arformoterol—Hypertension—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Arformoterol—Constipation—Vincristine—sarcoma	0.00177	0.00177	CcSEcCtD
Arformoterol—Pain—Vincristine—sarcoma	0.00177	0.00177	CcSEcCtD
Arformoterol—Dry skin—Epirubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Arformoterol—Chest pain—Etoposide—sarcoma	0.00174	0.00174	CcSEcCtD
Arformoterol—Hypokalaemia—Epirubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Arformoterol—Fatigue—Mitoxantrone—sarcoma	0.00173	0.00173	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00173	0.00173	CcSEcCtD
Arformoterol—Discomfort—Etoposide—sarcoma	0.00172	0.00172	CcSEcCtD
Arformoterol—Pain—Mitoxantrone—sarcoma	0.00172	0.00172	CcSEcCtD
Arformoterol—Constipation—Mitoxantrone—sarcoma	0.00172	0.00172	CcSEcCtD
Arformoterol—Hypersensitivity—Thiotepa—sarcoma	0.00172	0.00172	CcSEcCtD
Arformoterol—Nasopharyngitis—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Arformoterol—Hypersensitivity—Dactinomycin—sarcoma	0.0017	0.0017	CcSEcCtD
Arformoterol—Gastrointestinal pain—Vincristine—sarcoma	0.00169	0.00169	CcSEcCtD
Arformoterol—Gastritis—Epirubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Arformoterol—Anaphylactic shock—Etoposide—sarcoma	0.00167	0.00167	CcSEcCtD
Arformoterol—Asthenia—Thiotepa—sarcoma	0.00167	0.00167	CcSEcCtD
Arformoterol—Infection—Etoposide—sarcoma	0.00166	0.00166	CcSEcCtD
Arformoterol—Asthenia—Dactinomycin—sarcoma	0.00166	0.00166	CcSEcCtD
Arformoterol—Feeling abnormal—Mitoxantrone—sarcoma	0.00166	0.00166	CcSEcCtD
Arformoterol—Asthma—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Arformoterol—Influenza—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Arformoterol—Pruritus—Thiotepa—sarcoma	0.00165	0.00165	CcSEcCtD
Arformoterol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00164	0.00164	CcSEcCtD
Arformoterol—Dehydration—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Arformoterol—Tachycardia—Etoposide—sarcoma	0.00163	0.00163	CcSEcCtD
Arformoterol—Abdominal pain—Vincristine—sarcoma	0.00163	0.00163	CcSEcCtD
Arformoterol—Body temperature increased—Vincristine—sarcoma	0.00163	0.00163	CcSEcCtD
Arformoterol—Skin disorder—Etoposide—sarcoma	0.00162	0.00162	CcSEcCtD
Arformoterol—Dry skin—Doxorubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Arformoterol—Hypokalaemia—Doxorubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Arformoterol—Angina pectoris—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Arformoterol—Urticaria—Mitoxantrone—sarcoma	0.0016	0.0016	CcSEcCtD
Arformoterol—Diarrhoea—Thiotepa—sarcoma	0.00159	0.00159	CcSEcCtD
Arformoterol—Abdominal pain—Mitoxantrone—sarcoma	0.00159	0.00159	CcSEcCtD
Arformoterol—Body temperature increased—Mitoxantrone—sarcoma	0.00159	0.00159	CcSEcCtD
Arformoterol—Bronchitis—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Arformoterol—Diarrhoea—Dactinomycin—sarcoma	0.00158	0.00158	CcSEcCtD
Arformoterol—Nasopharyngitis—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Arformoterol—Hypotension—Etoposide—sarcoma	0.00156	0.00156	CcSEcCtD
Arformoterol—Gastritis—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Arformoterol—Dizziness—Thiotepa—sarcoma	0.00154	0.00154	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Arformoterol—Asthma—Doxorubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Arformoterol—Influenza—Doxorubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Arformoterol—Hypersensitivity—Vincristine—sarcoma	0.00152	0.00152	CcSEcCtD
Arformoterol—Dyspnoea—Etoposide—sarcoma	0.00149	0.00149	CcSEcCtD
Arformoterol—Hyperglycaemia—Epirubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Arformoterol—Somnolence—Etoposide—sarcoma	0.00149	0.00149	CcSEcCtD
Arformoterol—Angina pectoris—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Arformoterol—Hypersensitivity—Mitoxantrone—sarcoma	0.00148	0.00148	CcSEcCtD
Arformoterol—Asthenia—Vincristine—sarcoma	0.00148	0.00148	CcSEcCtD
Arformoterol—Vomiting—Thiotepa—sarcoma	0.00148	0.00148	CcSEcCtD
Arformoterol—Vomiting—Dactinomycin—sarcoma	0.00147	0.00147	CcSEcCtD
Arformoterol—Rash—Thiotepa—sarcoma	0.00147	0.00147	CcSEcCtD
Arformoterol—Bronchitis—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Arformoterol—Dermatitis—Thiotepa—sarcoma	0.00147	0.00147	CcSEcCtD
Arformoterol—Headache—Thiotepa—sarcoma	0.00146	0.00146	CcSEcCtD
Arformoterol—Rash—Dactinomycin—sarcoma	0.00146	0.00146	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Etoposide—sarcoma	0.00144	0.00144	CcSEcCtD
Arformoterol—Asthenia—Mitoxantrone—sarcoma	0.00144	0.00144	CcSEcCtD
Arformoterol—Fatigue—Etoposide—sarcoma	0.00144	0.00144	CcSEcCtD
Arformoterol—Pain—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Arformoterol—Constipation—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Arformoterol—Conjunctivitis—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Arformoterol—Urinary tract infection—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Arformoterol—Diarrhoea—Vincristine—sarcoma	0.00141	0.00141	CcSEcCtD
Arformoterol—Haematuria—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Arformoterol—Nausea—Thiotepa—sarcoma	0.00138	0.00138	CcSEcCtD
Arformoterol—Sinusitis—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Arformoterol—Feeling abnormal—Etoposide—sarcoma	0.00138	0.00138	CcSEcCtD
Arformoterol—Hyperglycaemia—Doxorubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Arformoterol—Diarrhoea—Mitoxantrone—sarcoma	0.00138	0.00138	CcSEcCtD
Arformoterol—Nausea—Dactinomycin—sarcoma	0.00137	0.00137	CcSEcCtD
Arformoterol—Gastrointestinal pain—Etoposide—sarcoma	0.00137	0.00137	CcSEcCtD
Arformoterol—Dizziness—Vincristine—sarcoma	0.00137	0.00137	CcSEcCtD
Arformoterol—Urticaria—Etoposide—sarcoma	0.00133	0.00133	CcSEcCtD
Arformoterol—Rhinitis—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Arformoterol—Abdominal pain—Etoposide—sarcoma	0.00132	0.00132	CcSEcCtD
Arformoterol—Body temperature increased—Etoposide—sarcoma	0.00132	0.00132	CcSEcCtD
Arformoterol—Conjunctivitis—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Arformoterol—Urinary tract infection—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Arformoterol—Vomiting—Vincristine—sarcoma	0.00131	0.00131	CcSEcCtD
Arformoterol—Pharyngitis—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Arformoterol—Urinary tract disorder—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Arformoterol—Rash—Vincristine—sarcoma	0.0013	0.0013	CcSEcCtD
Arformoterol—Dermatitis—Vincristine—sarcoma	0.0013	0.0013	CcSEcCtD
Arformoterol—Oedema peripheral—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Arformoterol—Haematuria—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Arformoterol—Connective tissue disorder—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Arformoterol—Urethral disorder—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Arformoterol—Headache—Vincristine—sarcoma	0.00129	0.00129	CcSEcCtD
Arformoterol—Vomiting—Mitoxantrone—sarcoma	0.00128	0.00128	CcSEcCtD
Arformoterol—Sinusitis—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Arformoterol—Visual impairment—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Arformoterol—Rash—Mitoxantrone—sarcoma	0.00127	0.00127	CcSEcCtD
Arformoterol—Dermatitis—Mitoxantrone—sarcoma	0.00127	0.00127	CcSEcCtD
Arformoterol—Headache—Mitoxantrone—sarcoma	0.00126	0.00126	CcSEcCtD
Arformoterol—Hypersensitivity—Etoposide—sarcoma	0.00123	0.00123	CcSEcCtD
Arformoterol—Nausea—Vincristine—sarcoma	0.00123	0.00123	CcSEcCtD
Arformoterol—Cardiac disorder—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Arformoterol—Rhinitis—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Arformoterol—Pharyngitis—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Arformoterol—Urinary tract disorder—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Arformoterol—Oedema peripheral—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Arformoterol—Asthenia—Etoposide—sarcoma	0.0012	0.0012	CcSEcCtD
Arformoterol—Connective tissue disorder—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Arformoterol—Urethral disorder—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Arformoterol—Nausea—Mitoxantrone—sarcoma	0.00119	0.00119	CcSEcCtD
Arformoterol—Immune system disorder—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Arformoterol—Mediastinal disorder—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Arformoterol—Pruritus—Etoposide—sarcoma	0.00118	0.00118	CcSEcCtD
Arformoterol—Arrhythmia—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Arformoterol—Visual impairment—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Arformoterol—Mental disorder—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Arformoterol—Malnutrition—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Arformoterol—Diarrhoea—Etoposide—sarcoma	0.00114	0.00114	CcSEcCtD
Arformoterol—Cardiac disorder—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Arformoterol—Tension—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Arformoterol—Dysgeusia—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Arformoterol—Nervousness—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Arformoterol—Back pain—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Arformoterol—Dizziness—Etoposide—sarcoma	0.00111	0.00111	CcSEcCtD
Arformoterol—Muscle spasms—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Arformoterol—Immune system disorder—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Arformoterol—Mediastinal disorder—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Arformoterol—Arrhythmia—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Arformoterol—Mental disorder—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Arformoterol—Ill-defined disorder—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Arformoterol—Vomiting—Etoposide—sarcoma	0.00106	0.00106	CcSEcCtD
Arformoterol—Malnutrition—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Arformoterol—Agitation—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Arformoterol—Rash—Etoposide—sarcoma	0.00105	0.00105	CcSEcCtD
Arformoterol—Dermatitis—Etoposide—sarcoma	0.00105	0.00105	CcSEcCtD
Arformoterol—Headache—Etoposide—sarcoma	0.00105	0.00105	CcSEcCtD
Arformoterol—Tension—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Arformoterol—Dysgeusia—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Arformoterol—Malaise—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Arformoterol—Nervousness—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Arformoterol—Back pain—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Arformoterol—Muscle spasms—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Arformoterol—Palpitations—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Arformoterol—Cough—Epirubicin—sarcoma	0.001	0.001	CcSEcCtD
Arformoterol—Nausea—Etoposide—sarcoma	0.000994	0.000994	CcSEcCtD
Arformoterol—Hypertension—Epirubicin—sarcoma	0.000992	0.000992	CcSEcCtD
Arformoterol—Ill-defined disorder—Doxorubicin—sarcoma	0.000986	0.000986	CcSEcCtD
Arformoterol—Chest pain—Epirubicin—sarcoma	0.000978	0.000978	CcSEcCtD
Arformoterol—Myalgia—Epirubicin—sarcoma	0.000978	0.000978	CcSEcCtD
Arformoterol—Arthralgia—Epirubicin—sarcoma	0.000978	0.000978	CcSEcCtD
Arformoterol—Agitation—Doxorubicin—sarcoma	0.000977	0.000977	CcSEcCtD
Arformoterol—Anxiety—Epirubicin—sarcoma	0.000975	0.000975	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000971	0.000971	CcSEcCtD
Arformoterol—Discomfort—Epirubicin—sarcoma	0.000966	0.000966	CcSEcCtD
Arformoterol—Malaise—Doxorubicin—sarcoma	0.000959	0.000959	CcSEcCtD
Arformoterol—Dry mouth—Epirubicin—sarcoma	0.000957	0.000957	CcSEcCtD
Arformoterol—Palpitations—Doxorubicin—sarcoma	0.000939	0.000939	CcSEcCtD
Arformoterol—Anaphylactic shock—Epirubicin—sarcoma	0.000938	0.000938	CcSEcCtD
Arformoterol—Oedema—Epirubicin—sarcoma	0.000938	0.000938	CcSEcCtD
Arformoterol—Infection—Epirubicin—sarcoma	0.000931	0.000931	CcSEcCtD
Arformoterol—Cough—Doxorubicin—sarcoma	0.000928	0.000928	CcSEcCtD
Arformoterol—Nervous system disorder—Epirubicin—sarcoma	0.000919	0.000919	CcSEcCtD
Arformoterol—Hypertension—Doxorubicin—sarcoma	0.000918	0.000918	CcSEcCtD
Arformoterol—Tachycardia—Epirubicin—sarcoma	0.000915	0.000915	CcSEcCtD
Arformoterol—Skin disorder—Epirubicin—sarcoma	0.000911	0.000911	CcSEcCtD
Arformoterol—Chest pain—Doxorubicin—sarcoma	0.000905	0.000905	CcSEcCtD
Arformoterol—Myalgia—Doxorubicin—sarcoma	0.000905	0.000905	CcSEcCtD
Arformoterol—Arthralgia—Doxorubicin—sarcoma	0.000905	0.000905	CcSEcCtD
Arformoterol—Anxiety—Doxorubicin—sarcoma	0.000902	0.000902	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000899	0.000899	CcSEcCtD
Arformoterol—Discomfort—Doxorubicin—sarcoma	0.000894	0.000894	CcSEcCtD
Arformoterol—Dry mouth—Doxorubicin—sarcoma	0.000885	0.000885	CcSEcCtD
Arformoterol—Hypotension—Epirubicin—sarcoma	0.000876	0.000876	CcSEcCtD
Arformoterol—Anaphylactic shock—Doxorubicin—sarcoma	0.000868	0.000868	CcSEcCtD
Arformoterol—Oedema—Doxorubicin—sarcoma	0.000868	0.000868	CcSEcCtD
Arformoterol—Infection—Doxorubicin—sarcoma	0.000862	0.000862	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000854	0.000854	CcSEcCtD
Arformoterol—Nervous system disorder—Doxorubicin—sarcoma	0.000851	0.000851	CcSEcCtD
Arformoterol—Insomnia—Epirubicin—sarcoma	0.000848	0.000848	CcSEcCtD
Arformoterol—Tachycardia—Doxorubicin—sarcoma	0.000847	0.000847	CcSEcCtD
Arformoterol—Skin disorder—Doxorubicin—sarcoma	0.000843	0.000843	CcSEcCtD
Arformoterol—Dyspnoea—Epirubicin—sarcoma	0.000836	0.000836	CcSEcCtD
Arformoterol—Somnolence—Epirubicin—sarcoma	0.000834	0.000834	CcSEcCtD
Arformoterol—Dyspepsia—Epirubicin—sarcoma	0.000825	0.000825	CcSEcCtD
Arformoterol—Hypotension—Doxorubicin—sarcoma	0.000811	0.000811	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000809	0.000809	CcSEcCtD
Arformoterol—Fatigue—Epirubicin—sarcoma	0.000808	0.000808	CcSEcCtD
Arformoterol—Pain—Epirubicin—sarcoma	0.000802	0.000802	CcSEcCtD
Arformoterol—Constipation—Epirubicin—sarcoma	0.000802	0.000802	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00079	0.00079	CcSEcCtD
Arformoterol—Insomnia—Doxorubicin—sarcoma	0.000785	0.000785	CcSEcCtD
Arformoterol—Dyspnoea—Doxorubicin—sarcoma	0.000773	0.000773	CcSEcCtD
Arformoterol—Feeling abnormal—Epirubicin—sarcoma	0.000773	0.000773	CcSEcCtD
Arformoterol—Somnolence—Doxorubicin—sarcoma	0.000771	0.000771	CcSEcCtD
Arformoterol—Gastrointestinal pain—Epirubicin—sarcoma	0.000767	0.000767	CcSEcCtD
Arformoterol—Dyspepsia—Doxorubicin—sarcoma	0.000764	0.000764	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000749	0.000749	CcSEcCtD
Arformoterol—Fatigue—Doxorubicin—sarcoma	0.000748	0.000748	CcSEcCtD
Arformoterol—Urticaria—Epirubicin—sarcoma	0.000745	0.000745	CcSEcCtD
Arformoterol—Pain—Doxorubicin—sarcoma	0.000742	0.000742	CcSEcCtD
Arformoterol—Constipation—Doxorubicin—sarcoma	0.000742	0.000742	CcSEcCtD
Arformoterol—Abdominal pain—Epirubicin—sarcoma	0.000741	0.000741	CcSEcCtD
Arformoterol—Body temperature increased—Epirubicin—sarcoma	0.000741	0.000741	CcSEcCtD
Arformoterol—Feeling abnormal—Doxorubicin—sarcoma	0.000715	0.000715	CcSEcCtD
Arformoterol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000709	0.000709	CcSEcCtD
Arformoterol—Hypersensitivity—Epirubicin—sarcoma	0.000691	0.000691	CcSEcCtD
Arformoterol—Urticaria—Doxorubicin—sarcoma	0.000689	0.000689	CcSEcCtD
Arformoterol—Body temperature increased—Doxorubicin—sarcoma	0.000686	0.000686	CcSEcCtD
Arformoterol—Abdominal pain—Doxorubicin—sarcoma	0.000686	0.000686	CcSEcCtD
Arformoterol—Asthenia—Epirubicin—sarcoma	0.000673	0.000673	CcSEcCtD
Arformoterol—Pruritus—Epirubicin—sarcoma	0.000663	0.000663	CcSEcCtD
Arformoterol—Diarrhoea—Epirubicin—sarcoma	0.000642	0.000642	CcSEcCtD
Arformoterol—Hypersensitivity—Doxorubicin—sarcoma	0.000639	0.000639	CcSEcCtD
Arformoterol—Asthenia—Doxorubicin—sarcoma	0.000622	0.000622	CcSEcCtD
Arformoterol—Dizziness—Epirubicin—sarcoma	0.00062	0.00062	CcSEcCtD
Arformoterol—Pruritus—Doxorubicin—sarcoma	0.000614	0.000614	CcSEcCtD
Arformoterol—Vomiting—Epirubicin—sarcoma	0.000596	0.000596	CcSEcCtD
Arformoterol—Diarrhoea—Doxorubicin—sarcoma	0.000594	0.000594	CcSEcCtD
Arformoterol—Rash—Epirubicin—sarcoma	0.000591	0.000591	CcSEcCtD
Arformoterol—Dermatitis—Epirubicin—sarcoma	0.000591	0.000591	CcSEcCtD
Arformoterol—Headache—Epirubicin—sarcoma	0.000587	0.000587	CcSEcCtD
Arformoterol—Dizziness—Doxorubicin—sarcoma	0.000574	0.000574	CcSEcCtD
Arformoterol—Nausea—Epirubicin—sarcoma	0.000557	0.000557	CcSEcCtD
Arformoterol—Vomiting—Doxorubicin—sarcoma	0.000552	0.000552	CcSEcCtD
Arformoterol—Rash—Doxorubicin—sarcoma	0.000547	0.000547	CcSEcCtD
Arformoterol—Dermatitis—Doxorubicin—sarcoma	0.000546	0.000546	CcSEcCtD
Arformoterol—Headache—Doxorubicin—sarcoma	0.000543	0.000543	CcSEcCtD
Arformoterol—Nausea—Doxorubicin—sarcoma	0.000515	0.000515	CcSEcCtD
